Taken together, our data suggest that the increased serum NGAL may be a sensitive marker in response to acute renal injury after stroke, which can be valuable as a complementary and alternative biomarker for predicting and diagnosis of AKI following stroke. This evidence concerns the gene LCN2 and stroke disorder.